CORC

浏览/检索结果: 共2条,第1-2条 帮助

限定条件                        
已选(0)清除 条数/页:   排序方式:
IXAZOMIB PLUS LENALIDOMIDE-DEXAMETHASONE (IRD) VS PLACEBO-RD IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): CHINA CONTINUATION OF TOURMALINE-MM1 会议论文
HAEMATOLOGICA, 2016-06-01
作者:  Hou, J.;  Jin, J.;  Xu, Y.;  Wu, D.;  Ke, X.
收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04
Ixazomib plus lenalidomide-dexamethasone (IRd) vs placebo-Rd in patients (pts) with relapsed/refractory multiple myeloma (RRMM): China continuation of TOURMALINE-MM1. 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20
作者:  Hou, Jian;  Jin, Jie;  Xu, Yan;  Wu, Depei;  Ke, Xiaoyan
收藏  |  浏览/下载:1/0  |  提交时间:2020/01/04


©版权所有 ©2017 CSpace - Powered by CSpace